Homegrown private equity firm Samara Capital has emerged as one of the frontrunners to invest in a Mumbai-based pharmaceutical development and manufacturing company, two people ..
Eris Lifesciences Ltd, a Mumbai-listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, has agreed to purchase Biocon Biologics Ltd’s dermatology and ..
Eris Lifesciences has announced that it has reached a definitive agreement to acquire the dermatology and nephrology branded formulations business units of Biocon Biologics in India. The deal is valued at Rs 366 crore. The acquisition will be partially funded through debt financing.
Eris Lifesciences has been on an acquisition spree in a bid to diversify its offerings. The company recently bought nine dermatology brands from both Dr Reddy’s Laboratories and Glenmark Pharma.